J. Puymirat

发表

Phylogenetic and familial estimates of mitochondrial substitution rates: study of control region mutations in deep-rooting pedigrees.

D. Labuda, E. Ziętkiewicz, E. Heyer, 2001, American journal of human genetics.

The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases

Francesco Muntoni, Hanns Lochmüller, Alessandra Renieri, 2014, European Journal of Human Genetics.

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial

T. Ashizawa, S. Rogers, J. McClure, 2020, PloS one.

Towards development of a statistical framework to evaluate myotonic dystrophy type 1 mRNA biomarkers in the context of a clinical trial

T. Ashizawa, S. Rogers, J. McClure, 2019, bioRxiv.

The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care

F. Rivier, F. Chapon, C. Richelme, 2019, Orphanet Journal of Rare Diseases.

Correction of GSK3ß at young age prevents muscle pathology in mice with myotonic dystrophy type 1

J. Woodgett, D. Witte, J. Puymirat, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Anticipation in myotonic dystrophy type 1 parents with small CTG expansions

J. Puymirat, J. Mathieu, A. Pratte, 2015, American journal of medical genetics. Part A.

Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1

S. Freier, J. Puymirat, S. Pandey, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1 s

S. Freier, J. Puymirat, S. Pandey, 2015 .

Altered signal transduction pathways and induction of autophagy in human myotonic dystrophy type 1 myoblasts.

J. Puymirat, D. Furling, M. Simili, 2010, The international journal of biochemistry & cell biology.

Sibship stability of genotype and phenotype in myotonic dystrophy

J. Puymirat, C. Laberge, J. Mathieu, 2002, Clinical genetics.

Effect of Polyunsaturated Fatty Acids on Fetal Mouse Brain Cells in Culture in a Chemically Defined Medium

J. Puymirat, J. Bourre, A. Tixier-vidal, 1983, Journal of neurochemistry.

Differentiation of fetal mouse hypothalamic cells in serum-free medium.

J. Puymirat, D. Grouselle, A. Tixier-vidal, 1981, Developmental neuroscience.

Release of immunoreactive TRH in serum-free cultures of mouse hypothalamic cells.

J. Puymirat, D. Grouselle, A. Barret, 1983, Brain research.

Effects of dysthyroidism on central catecholaminergic neurons

J. Puymirat, 1985, Neurochemistry International.

Does triiodothyronine influence the morphogenesis of fetal mouse mesencephalic dopaminergic neurons cultured in chemically defined medium?

J. Puymirat, A. Barret, A. Tixier-vidal, 1985, Brain research.

Evolution of triiodothyronine nuclear binding sites in hypothalamic serum-free cultures: Evidence for their presence in neurons and astrocytes

J. Puymirat, A. Faivre-Bauman, A. Faivre‐Bauman, 1986, Neuroscience Letters.

Biochemical characterization of the uptake and release of [3H]dopamine by dopaminergic hypothalamic neurons: a developmental study using serum-free medium cultures.

J. Puymirat, A. Barret, A. Tixier-vidal, 1987, Developmental biology.

Immunocytochemical localization of thyroid hormone nuclear receptors in cultured hypothalamic dopaminergic neurons

J. Puymirat, J. Dussault, M. Luo, 1989, Neuroscience.

Identification of predictors of response to Erenumab in a cohort of patients with migraine

J. Puymirat, D. Simonyan, H. Salem-Abdou, 2021, Cephalalgia Reports.

Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1

G. Bassez, J. Puymirat, J. Hogrel, 2017, Annals of clinical and translational neurology.

Eight years after an international workshop on myotonic dystrophy patient registries: case study of a global collaboration for a rare disease

G. Bassez, J. Puymirat, H. Lochmüller, 2018, Orphanet Journal of Rare Diseases.

Developing registries of volunteers: key principles to manage issues regarding personal information protection

B. Knoppers, J. Puymirat, E. Lévesque, 2010, Journal of Medical Ethics.

Patients with Alzheimer's disease show an increased content of 15 Kdalton somatostatin precursor and a lowered level of tetradecapeptide in their cerebrospinal fluid.

J. Puymirat, P. Rondot, P. Cohen, 1986, Life sciences.

Thyroid Hormones Stabilize Acetylcholinesterase mRNA in Neuro-2A Cells That Overexpress the β1 Thyroid Receptor (*)

J. Puymirat, J. Dussault, P. Étongué‐Mayer, 1995, The Journal of Biological Chemistry.

POST MORTEM STABILITY AND STORAGE IN THE COLD OF BRAIN ENZYMES

P. Gaspar, A. Prochiantz, Y. Agid, 1979, Journal of neurochemistry.

Clinical and Electrophysiological Study in French-Canadian Population with Charcot-Marie-Tooth Disease Type 1 A Associated with 17 pll . 2 Duplication

J. Bouchard, J. Puymirat, D. Brunet, 2015 .

A Founder Mutation in French-Canadian Families with X-linked Hereditary Neuropathy

J. Bouchard, G. Rouleau, G. Rouleau, 2001, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Clinical and Electrophysiological Study in French-Canadian Population with Charcot-Marie-Tooth Disease Type 1A Associated with 17p11.2 Duplication

J. Bouchard, J. Puymirat, D. Brunet, 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Red blood cell Cu Zn superoxide dismutase activity in sporadic amyotrophic lateral sclerosis

J. Bouchard, J. Puymirat, L. Cossette, 1994, Journal of the Neurological Sciences.

Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

R. Laforce, J. Puymirat, N. Sergeant, 2022, Journal of Neurology.

Transgenic Glutathione Peroxidase Mouse Models for Neuroprotection Studies a

J. Puymirat, D. Furling, A. Tremblay, 1994, Annals of the New York Academy of Sciences.

Implication of SPARC in the modulation of the extracellular matrix and mitochondrial function in muscle cells

J. Puymirat, M. Yoshioka, J. St-Amand, 2018, PloS one.

The α and β thyroid receptors are expressed by cultured ependymal cells. Correlation with the effect of l-3,5,3′-triiodothyronine on glutamine synthetase mRNAs

J. Puymirat, D. Baas, J. Delaunoy, 1993, Neuroscience Letters.

Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting DMPK Transcripts for the Treatment of Myotonic Dystrophy Type 1.

M. Boutjdir, J. Puymirat, F. Rigo, 2022, Human gene therapy.

iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities

M. Boutjdir, J. Puymirat, I. Deschênes, 2021, Scientific Reports.

Correction of GSK3 b at young age prevents muscle pathology in mice with myotonic dystrophy type 1

J. Woodgett, D. Witte, J. Puymirat, 2018 .

A novel founder SCN4A mutation causes painful cold-induced myotonia in French-Canadians

I. Thiffault, B. Brais, J. Puymirat, 2007, Neurology.

Insulin-like growth factor I circumvents defective insulin action in human myotonic dystrophy skeletal muscle cells.

A. Marette, J. Puymirat, D. Furling, 1999, Endocrinology.

Clinical, electrophysiologic, and genetic study of non-dystrophic myotonia in French-Canadians

J. Bouchard, B. Brais, J. Puymirat, 2009, Neuromuscular Disorders.

Investigation of Myelinogenesis in Vitro: Transient Expression of 3,5,3’-Triiodothyronine Nuclear Receptors in Secondary Cultures of Pure Rat Oligodendrocytes

B. Yusta, J. Puymirat, Á. Pascual, 1989 .

Increase in the proliferative capacity of human myoblasts by using the T antigen under the vimentin promoter control

J. Tremblay, J. Puymirat, I. Deschênes, 1997, Muscle & nerve.

Myoblast transplantations lead to the expression of the laminin α2 chain in normal and dystrophic (dy/dy) mouse muscles

J. Puymirat, M. Fiszman, M. Fardeau, 1999, Gene Therapy.

Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3′-triiodo-l-thyronine

J. Puymirat, D. Baas, C. Fressinaud, 1994, Neuroscience Letters.

Transient expression of 3,5,3′‐triiodothyronine nuclear receptors in rat oligodendrocytes: In vivo and in vitro immunocytochemical studies

J. Puymirat, M. Miehe, F. Besnard, 1994, Journal of neuroscience research.

Myotonia congenita—a cause of muscle weakness and stiffness

J. Bouchard, J. Puymirat, N. Dupré, 2006, Nature Clinical Practice Neurology.

Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type

J. Puymirat, P. Rondot, P. Davous, 1986, Psychoneuroendocrinology.

Immunocytochemical localization of nuclear 3,5,3'-triiodothyronine (L-T3) receptors in astrocyte cultures.

J. Puymirat, J. Dussault, M. Luo, 1989, Brain research. Developmental brain research.

Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1

M. Boutjdir, J. Puymirat, M. Chahine, 2022, International journal of molecular sciences.

Thyroid hormone up‐regulates thyroid hormone receptor β gene expression in rat cerebral hemisphere astrocyte cultures

J. Puymirat, J. Lebel, J. Dussault, 1993, Glia.

Expression of thyroid hormone receptors mRNAs in rat cerebral hemisphere neuronal cultures.

J. Puymirat, J. Dussault, S. l'Héreault, 1992, Brain research. Developmental brain research.

Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)200 expansion in the DMPK gene: CHUQi001-A.

J. Puymirat, L. Martineau, Véronique Racine, 2018, Stem cell research.

Consensus-based care recommendations for adults with myotonic dystrophy type 1

P. Nopoulos, M. Bozzali, S. Pandya, 2018, Neurology. Clinical practice.

Expression of Microtubule‐Associated Proteins During the Early Stages of Neurite Extension by Brain Neurons Cultured in a Defined Medium

J. Puymirat, J. Nunez, J. Guilleminot, 1986, Journal of neurochemistry.

Overexpression of the beta 1 thyroid receptor induces differentiation in neuro-2a cells.

J. Puymirat, J. Lebel, J. Dussault, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells1.

A. Marette, J. Puymirat, D. Furling, 1999, Endocrinology.

Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions

J. Puymirat, C. Laberge, J. Mathieu, 2006, Neurology.

Precocious auto-induction of thyroid hormone receptors in embryonic chick hypothalamic neurons

J. Puymirat, B. Demeneix, F. Lezoualc'h, 1994, Neuroscience Letters.

Laminin promotes attachment and neurite elongation of fetal hypothalamic neurons grown in serum-free medium

J. Puymirat, A. Barret, A. Tixier-vidal, 1984, Neuroscience Letters.

Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions

G. Doucet, J. Puymirat, D. Furling, 2003, Gene Therapy.

RNA based gene therapy for dominantly inherited diseases.

J. Puymirat, S. Caron, R. Pelletier, 2006, Current gene therapy.

Cytoplasmic and Nuclear Retained DMPK mRNAs Are Targets for RNA Interference in Myotonic Dystrophy Cells*

G. Wang, J. Rossi, J. Puymirat, 2005, Journal of Biological Chemistry.

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice

G. Bassez, J. Puymirat, S. Pandey, 2017, Molecular therapy. Nucleic acids.

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

J. Puymirat, M. Chahine, Marion Pierre, 2021, Neurobiology of Disease.

RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression

A. Tucker, O. Prall, R. Harvey, 2008, Nature Genetics.

Immortalized human myotonic dystrophy muscle cell lines to assess therapeutic compounds

M. Tarnopolsky, J. Puymirat, A. Boland, 2017, Disease Models & Mechanisms.

Relationship between muscle impairments, postural stability, and gait parameters assessed with lower-trunk accelerometry in myotonic dystrophy type 1

Luc J. Hébert, Guillaume Bassez, Bruno Eymard, 2016, Neuromuscular Disorders.

Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.

J. Bouchard, J. Puymirat, J. Mathieu, 2012, Clinical therapeutics.

Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts

J. Puymirat, D. Furling, K. Taneja, 2001, Neuromuscular Disorders.

Immunocytochemical localization of thyroid hormone nuclear receptors in cultured acetylcholinesterase-positive neurons: A correlation between the presence of thyroid hormone nuclear receptors and l-tri-iodothyronine morphological effects

J. Puymirat, J. Dussault, R. Garza, 1990, Neuroscience.

Immunocytochemical localization of thyroid hormone receptors in the adult rat brain.

J. Puymirat, M. Miehe, J. Dussault, 1991, Thyroid : official journal of the American Thyroid Association.

Basic Transcription Element-binding Protein (BTEB) Is a Thyroid Hormone-regulated Gene in the Developing Central Nervous System

R J Denver, L Ouellet, D Furling, 1999, The Journal of Biological Chemistry.

rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences

G. Meola, G. Bassez, J. Puymirat, 2018, Nature Communications.

Absence of a differentiation defect in muscle satellite cells from DM2 patients

M. Tarnopolsky, J. Puymirat, B. Schoser, 2009, Neurobiology of Disease.

RBFOX 1 Cooperates with MBNL 1 to Control Splicing in Muscle , Including Events Altered in Myotonic Dystrophy Type 1

G. Meola, J. Puymirat, Johanne Toutant, 2018 .

RBFOX1 Cooperates with MBNL1 to Control Splicing in Muscle, Including Events Altered in Myotonic Dystrophy Type 1

G. Meola, J. Puymirat, Johanne Toutant, 2014, PloS one.

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study

F. Chapon, A. Geille, G. Bassez, 2016, PloS one.

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

J. Puymirat, F. Rigo, C. Bennett, 2022, Gene therapy.

Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.

J. Rossi, J. Puymirat, N. Lee, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 Locus

F. Metzger, A. Munnich, A. Hoeflich, 2012, PLoS genetics.

Estimating Y chromosome specific microsatellite mutation frequencies using deep rooting pedigrees.

P. de Knijff, E. Heyer, J. Puymirat, 1997, Human molecular genetics.

Localization of cells in the rat brain expressing fumarylacetoacetate hydrolase, the deficient enzyme in hereditary tyrosinemia type 1.

J. Puymirat, Y. Labelle, R. Tanguay, 1993, Biochimica et biophysica acta.

HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence

A. Riggs, J. Rossi, J. Puymirat, 2005, Nucleic acids research.

Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases

J. Bouchard, G. Bassez, J. Puymirat, 2015, Journal of Neurology.

Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI

M. Janier, J. Puymirat, L. Hébert, 2012, Journal of magnetic resonance imaging : JMRI.

Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone

J. Puymirat, D. Baas, J. Dussault, 1997, Glia.

Translating the Genomics Revolution: The Need for an International Gene Therapy Consortium for Monogenic Diseases

J. Joung, C. Barbas, A. Bogdanove, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Biophysical characterization of M1476I, a sodium channel founder mutation associated with cold‐induced myotonia in French Canadians

J. Puymirat, N. Dupré, M. Chahine, 2012, The Journal of physiology.

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice

G. Bassez, J. Puymirat, M. Wood, 2019, The Journal of clinical investigation.

Influence of soluble environmental factors on the development of fetal brain acetylcholinesterase-positive neurons cultured in a chemically defined medium: comparison with the effects of L-triiodothyronine (L-T3).

J. Puymirat, J. Dussault, R. Garza, 1990, Brain research. Developmental brain research.

Report of the first Outcome Measures in Myotonic Dystrophy type 1 (OMMYD-1) international workshop Clearwater, Florida, November 30, 2011

G. Meola, J. Puymirat, L. Hébert, 2013, Neuromuscular Disorders.

Triiodothyronine enhances the morphological maturation of dopaminergic neurons from fetal mouse hypothalamus cultured in serum-free medium

A. Vigny, J. Puymirat, R. Picart, 1983, Neuroscience.

Influence of triiodothyronine (L-T3) on the morphological and biochemical development of fetal brain acetylcholinesterase-positive neurons cultured in a chemically defined medium.

J. Puymirat, J. Dussault, R. Garza, 1988, Brain research.

The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study

J. Puymirat, L. Hébert, C. Vial, 2010, BMC musculoskeletal disorders.

Posttranscriptional regulation of oligodendroglial thyroid hormone (T3) receptor β1 by T3

J. Puymirat, D. Baas, L. Sarliève, 1998, International Journal of Developmental Neuroscience.

Generation of four myotonic dystrophy type 1 patient iPSC lines (CBRCULi002-A, CBRCULi003-A, CBRCULi004-A, CBRCULi005-A) and a control (CBRCULi001-A) derived from lymphoblastoids cell lines.

M. Boutjdir, J. Puymirat, M. Chahine, 2023, Stem cell research.

Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy

M. Tarnopolsky, J. Puymirat, D. Furling, 2012, Neurobiology of Disease.

FAMILIES WITH MYOTONIC DYSTROPHY TYPE 1 INTERGENERATIONAL CONTRACTION OF THE CTG REPEATS IN 2

J. Bouchard, J. Puymirat, J. Mathieu, 2010 .

INTERGENERATIONAL CONTRACTION OF THE CTG REPEATS IN 2 FAMILIES WITH MYOTONIC DYSTROPHY TYPE 1

J. Bouchard, J. Puymirat, J. Mathieu, 2009, Neurology.

Transplantation of human myoblasts in SCID mice as a potential muscular model for myotonic dystrophy.

J. Bouchard, J. Puymirat, D. Furling, 1999, Journal of neuropathology and experimental neurology.

Founder SH3TC2 mutations are responsible for a CMT4C French-Canadians cluster

V. Chau, I. Thiffault, B. Brais, 2008, Neuromuscular Disorders.

Immunocytochemical localization of seleno-glutathione peroxidase in the adult mouse brain

J. Puymirat, D. Furling, M. Mirault, 1996, Neuroscience.

Dosage Effect of a Dominant CLCN1 Mutation: A Novel Syndrome

J. Puymirat, M. Shevell, G. Bernard, 2008, Journal of child neurology.

Acetylcholinesterase activity and somatostatin-like immunoreactivity in Lumbar cerebrospinal fluid of demented patients

J. Puymirat, P. Rondot, P. Davous, 1986 .

Characterization of a 54‐kilodalton human protein kinase recognized by an antiserum raised against the myotonin kinase

J. Bouchard, J. Puymirat, R. Faure, 1998, Muscle & nerve.

Prenatal and postnatal ontogenesis of neurotransmitter-synthetizing enzymes and [125I]tetanus toxin binding capacity in the mouse hypothalamus.

J. Puymirat, A. Tixier-vidal, B. Bizzini, 1982, Brain research.

Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin–proteasome pathway

J. Puymirat, G. Butler-Browne, D. Furling, 2010, Neuromuscular Disorders.

Evidence for the presence of alpha and beta-related T3 receptors in rat liver mitochondria.

J. Puymirat, G. Morel, D. Ardail, 1993, European journal of cell biology.

INCREASED GRANZYME B mRNA AFTER ALLOINCOMPATIBLE MYOBLAST TRANSPLANTATION

J. Puymirat, R. Roy, B. Guérette, 1995, Transplantation.

Thyroid receptors in the rat brain

J. Puymirat, 1992, Progress in Neurobiology.

Expression of α and β thyroid receptors during oligodendrocyte differentiation

J. Puymirat, D. Baas, J. Dussault, 1994 .

Regional changes in β 1 thyroid hormone receptor immunoreactivity in rat brain after thyroidectomy

J. Nobrega, J. Puymirat, R. Joffe, 1997, Brain Research.

Intracellular ribozyme applications.

J. Rossi, J. Puymirat, N. Lee, 2001, Biochemical Society transactions.

Differentiation of lymphoblastoid-derived iPSCs into functional cardiomyocytes, neurons and myoblasts.

J. Puymirat, M. Chahine, Hugo Poulin, 2019, Biochemical and biophysical research communications.

Immunocytochemical localization of β thyroid receptor in the rat cerebellum

J. Puymirat, J. Dussault, R. Marchand, 1992, Neuroscience Letters.

Suppression of the basic transcription element-binding protein in brain neuronal cultures inhibits thyroid hormone-induced neurite branching.

J. Puymirat, R. Denver, Christelle Cayrou, 2002, Endocrinology.

The expression of nuclear 3,5,3′ triiodothyronine receptors is induced in Schwann cells by nerve transection

B. Droz, J. Puymirat, J. Dussault, 1992, Experimental Neurology.

Generation of a human induced pluripotent stem cell line (UQACi001-A) from a severe epidermolysis bullosa simplex patient with the heterozygous mutation p.R125S in the KRT14 gene.

C. Laprise, J. Puymirat, J. Powell, 2020, Stem cell research.

Changes in Nuclear 3,5,3′‐Triiodothyronine Receptor Expression in Rat Dorsal Root Ganglia and Sciatic Nerve During Development: Comparison with Regeneration

J. Puymirat, C. Due, I. Barakat‐Walter, 1993, The European journal of neuroscience.

Quantitative assessment of skeletal muscle degeneration in patients with myotonic dystrophy type 1 using MRI

M. Janier, J. Puymirat, L. Hébert, 2012, Journal of magnetic resonance imaging : JMRI.

Abnormal prostaglandin E2 production blocks myogenic differentiation in myotonic dystrophy

M. Tarnopolsky, J. Puymirat, D. Furling, 2012, Neurobiology of Disease.